96 related articles for article (PubMed ID: 10023675)
1. Physical interaction of the bHLH LYL1 protein and NF-kappaB1 p105.
Ferrier R; Nougarede R; Doucet S; Kahn-Perles B; Imbert J; Mathieu-Mahul D
Oncogene; 1999 Jan; 18(4):995-1005. PubMed ID: 10023675
[TBL] [Abstract][Full Text] [Related]
2. Helix-loop-helix proteins LYL1 and E2a form heterodimeric complexes with distinctive DNA-binding properties in hematolymphoid cells.
Miyamoto A; Cui X; Naumovski L; Cleary ML
Mol Cell Biol; 1996 May; 16(5):2394-401. PubMed ID: 8628307
[TBL] [Abstract][Full Text] [Related]
3. TAL1, TAL2 and LYL1: a family of basic helix-loop-helix proteins implicated in T cell acute leukaemia.
Baer R
Semin Cancer Biol; 1993 Dec; 4(6):341-7. PubMed ID: 8142619
[TBL] [Abstract][Full Text] [Related]
4. TPL-2 kinase regulates the proteolysis of the NF-kappaB-inhibitory protein NF-kappaB1 p105.
Belich MP; Salmerón A; Johnston LH; Ley SC
Nature; 1999 Jan; 397(6717):363-8. PubMed ID: 9950430
[TBL] [Abstract][Full Text] [Related]
5. Products of the TAL2 oncogene in leukemic T cells: bHLH phosphoproteins with DNA-binding activity.
Xia Y; Hwang LY; Cobb MH; Baer R
Oncogene; 1994 May; 9(5):1437-46. PubMed ID: 8152805
[TBL] [Abstract][Full Text] [Related]
6. The ankyrin repeat domains of the NF-kappa B precursor p105 and the protooncogene bcl-3 act as specific inhibitors of NF-kappa B DNA binding.
Hatada EN; Nieters A; Wulczyn FG; Naumann M; Meyer R; Nucifora G; McKeithan TW; Scheidereit C
Proc Natl Acad Sci U S A; 1992 Mar; 89(6):2489-93. PubMed ID: 1532257
[TBL] [Abstract][Full Text] [Related]
7. The activity of a 70 kilodalton I kappa B molecule identical to the carboxyl terminus of the p105 NF-kappa B precursor is modulated by protein kinase A.
Gerondakis S; Morrice N; Richardson IB; Wettenhall R; Fecondo J; Grumont RJ
Cell Growth Differ; 1993 Aug; 4(8):617-27. PubMed ID: 8398903
[TBL] [Abstract][Full Text] [Related]
8. NF-kappaB p105 is a target of IkappaB kinases and controls signal induction of Bcl-3-p50 complexes.
Heissmeyer V; Krappmann D; Wulczyn FG; Scheidereit C
EMBO J; 1999 Sep; 18(17):4766-78. PubMed ID: 10469655
[TBL] [Abstract][Full Text] [Related]
9. Characterization of ES cells deficient for the p105 precursor (NF-kappa B1): role of p50 NLS.
Ishikawa H; Ryseck RP; Bravo R
Oncogene; 1996 Jul; 13(2):255-63. PubMed ID: 8710364
[TBL] [Abstract][Full Text] [Related]
10. Promoter of the human NF-kappa B p50/p105 gene. Regulation by NF-kappa B subunits and by c-REL.
Cogswell PC; Scheinman RI; Baldwin AS
J Immunol; 1993 Apr; 150(7):2794-804. PubMed ID: 8454856
[TBL] [Abstract][Full Text] [Related]
11. HTLV-I encoded Tax in association with NF-kappa B precursor p105 enhances nuclear localization of NF-kappa B p50 and p65 in transfected cells.
Watanabe M; Muramatsu M; Hirai H; Suzuki T; Fujisawa J; Yoshida M; Arai K; Arai N
Oncogene; 1993 Nov; 8(11):2949-58. PubMed ID: 8414497
[TBL] [Abstract][Full Text] [Related]
12. Cyclosporin A interferes with the inducible degradation of NF-kappa B inhibitors, but not with the processing of p105/NF-kappa B1 in T cells.
Marienfeld R; Neumann M; Chuvpilo S; Escher C; Kneitz B; Avots A; Schimpl A; Serfling E
Eur J Immunol; 1997 Jul; 27(7):1601-9. PubMed ID: 9247567
[TBL] [Abstract][Full Text] [Related]
13. Lyl1 interacts with CREB1 and alters expression of CREB1 target genes.
San-Marina S; Han Y; Suarez Saiz F; Trus MR; Minden MD
Biochim Biophys Acta; 2008 Mar; 1783(3):503-17. PubMed ID: 18160048
[TBL] [Abstract][Full Text] [Related]
14. Overexpression of a transcription factor LYL1 induces T- and B-cell lymphoma in mice.
Zhong Y; Jiang L; Hiai H; Toyokuni S; Yamada Y
Oncogene; 2007 Oct; 26(48):6937-47. PubMed ID: 17486074
[TBL] [Abstract][Full Text] [Related]
15. Casper/c-FLIP is physically and functionally associated with NF-kappaB1 p105.
Li Z; Zhang J; Chen D; Shu HB
Biochem Biophys Res Commun; 2003 Oct; 309(4):980-5. PubMed ID: 13679070
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of p105 processing by NF-kappaB proteins in transiently transfected cells.
Harhaj EW; Maggirwar SB; Sun SC
Oncogene; 1996 Jun; 12(11):2385-92. PubMed ID: 8649779
[TBL] [Abstract][Full Text] [Related]
17. Multiple mechanisms induce ectopic expression of LYL1 in subsets of T-ALL cell lines.
Nagel S; Venturini L; Meyer C; Kaufmann M; Scherr M; Drexler HG; MacLeod RA
Leuk Res; 2010 Apr; 34(4):521-8. PubMed ID: 19608273
[TBL] [Abstract][Full Text] [Related]
18. The NF-kappa B p50 precursor, p105, contains an internal I kappa B-like inhibitor that preferentially inhibits p50.
Liou HC; Nolan GP; Ghosh S; Fujita T; Baltimore D
EMBO J; 1992 Aug; 11(8):3003-9. PubMed ID: 1639070
[TBL] [Abstract][Full Text] [Related]
19. The NF-kappa B precursor p105 and the proto-oncogene product Bcl-3 are I kappa B molecules and control nuclear translocation of NF-kappa B.
Naumann M; Wulczyn FG; Scheidereit C
EMBO J; 1993 Jan; 12(1):213-22. PubMed ID: 8428580
[TBL] [Abstract][Full Text] [Related]
20. Regulation of NF-kappa B, AP-1, NFAT, and STAT1 nuclear import in T lymphocytes by noninvasive delivery of peptide carrying the nuclear localization sequence of NF-kappa B p50.
Torgerson TR; Colosia AD; Donahue JP; Lin YZ; Hawiger J
J Immunol; 1998 Dec; 161(11):6084-92. PubMed ID: 9834092
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
